| ATCC 49165| DSM 3662| Eubacterium callanderi| Eubacterium callanderi Mountfort et al. 1988| JCM 10284| strain FD
Gut microbiota: Eubacterium callanderi is commonly found in the human gastrointestinal tract as part of the gut microbiota. The gut microbiota plays a crucial role in host health, contributing to various physiological processes such as digestion, immune modulation, and nutrient metabolism.
Short-chain fatty acid production: Like many other bacteria in the gut microbiota, Eubacterium callanderi is likely involved in the fermentation of dietary carbohydrates and other substrates in the gut. Through fermentation, these bacteria produce metabolites such as short-chain fatty acids (SCFAs), including acetate, propionate, and butyrate. SCFAs are important for gut health and overall well-being, as they serve as an energy source for colonic epithelial cells, regulate immune function, and exert anti-inflammatory effects.
Butyrate production: Some species within the genus Eubacterium are known for their ability to produce butyrate, a type of short-chain fatty acid with various health benefits. Butyrate has been shown to promote gut barrier function, modulate immune responses, and reduce inflammation in the gut. While the specific butyrate-producing capabilities of Eubacterium callanderi have not been extensively studied, its presence in the gut microbiota suggests a potential role in butyrate production and its associated health benefits.
Metabolic health: Alterations in the composition and activity of gut bacteria, including Eubacterium species, have been associated with various metabolic disorders such as obesity, type 2 diabetes, and metabolic syndrome. While the specific contributions of Eubacterium callanderi to metabolic health are not well-understood, its interactions with other gut microbes and host physiology may influence metabolic processes and contribute to the development or progression of metabolic diseases.
Host-microbe interactions: Eubacterium callanderi may interact with the host immune system and other components of the gut environment. These interactions can influence immune homeostasis, gut epithelial integrity, and the balance between health and disease in the gut.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.79 | 10 | 230 | 0 | 188 | 77.1 | 65 | 56.5 | 10 | 230 | 0 %ile | 100 %ile | ||
biomesight | 64.67 | 0 | 50 | 10 | 120 | 0 | 1517 | 126.3 | 50 | 709.6 | 10 | 150 | 3.4 %ile | 90.4 %ile |
thorne | 100 | 22 | 336 | 0 | 239 | 94.3 | 68 | 73.9 | 36 | 172 | 0 %ile | 100 %ile | ||
thryve | 0.09 | 0 | 50 | 50 | 50 | 50 | 50 | 0 %ile | 99 %ile | |||||
ubiome | 2.15 | 21 | 8570 | 0 | 4740 | 754.1 | 137 | 2033.6 | 21 | 8570 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 70.874 % | 0.012 % | 0.063 % | 2100.0 | 2963 |
BiomeSightRdp | 16.129 % | 0.006 % | 0.005 % | 5.0 | 31 |
bugspeak | 100 % | 0.013 % | % | 1.0 | 1 |
CerbaLab | 100 % | 0.01 % | 0.003 % | 3.0 | 3 |
CosmosId | 9.375 % | 0.004 % | 0.003 % | 3.0 | 32 |
custom | 6.557 % | 0.005 % | 0.005 % | 4.0 | 61 |
es-xenogene | 13.793 % | 0.012 % | 0.008 % | 4.0 | 29 |
Thorne | 85.577 % | 0.007 % | 0.008 % | 89.0 | 104 |
Thryve | 0.144 % | 0.004 % | 0.002 % | 2.0 | 1390 |
uBiome | 2.146 % | 0.075 % | 0.203 % | 17.0 | 792 |
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.